Clinical Trial Assays in Precision Medicine: Expert Perspectives from Diagnostics & Pharma
Almac Diagnostic Services invites you to Boston for an exclusive, invite-only, in-person event.
At this thought leadership event, we will explore clinical trial assays in precision medicine, examined through two distinct perspectives.
The session will focus on the key considerations for development and deployment of biomarker driven clinical trial assays for use in global clinical trials, with insights shared by senior leaders from Eli Lilly, Merck and Almac.
Join us in-person
Date: Tuesday 24th March 2026
Location: Le Méridien Hotel, Boston
Time: 8.30am – 1.00pm
Spaces are limited and on an invite-only basis
To secure your place, please confirm your attendance as soon as possible by completing the registration form.
Your expert speakers for the event will be:
Your expert speakers for the event will be:
Anthony Sireci MD
(Guest Speaker)
Senior Vice President, Clinical Biomarkers & Diagnostics Development, Eli Lilly
Latisha Love-Gregory
(Guest Speaker)
Translational Molecular Biomarkers Genomics Lead / Director, Merck
Katarina Wikstrom
Global VP of Product Development, Almac Diagnostic Services
Connect on LinkedIn
Leeona Galligan
Global VP of Clinical Testing, Almac Diagnostic Services, Almac Diagnostic Services
Connect on LinkedIn
Stewart McWilliams
Global VP of Quality & Regulatory Affairs, Almac Diagnostic Services
Connect on LinkedIn
Invitation & Agenda
| Time | Topic |
| 8.30 – 9.00am | Arrival, Breakfast & Registration Guests arrive for a light breakfast option and tea coffee. Opportunity to network. |
| 9.00 – 10.00am | Almac Presentations Almac Dx presentations on Clinical Trial Assays. Speakers: • Michael Sloan, Global Vice President Commercial Operations, Almac • Katarina Wikstrom, Global VP of Product Development, Almac • Leeona Galligan, Global VP of Clinical Testing, Almac • Stewart McWilliams, Global VP of Quality & Regulatory Affairs, Almac |
| 10.00 – 11.00am | Invited Guest Presentations Pharma Industry Guest Presenters. Perspectives on Clinical Trial Assays. Speakers: • Anthony Sireci, Senior Vice President, Clinical Biomarkers & Diagnostics Development, Eli Lilly • Latisha Love-Gregory, Translational Molecular Biomarkers Genomics Lead / Director, Merck |
| 11.00 – 11.30am | Break Networking and Refreshments. |
| 11.30 – 12.00am | Panel Discussion Facilitated Panel Discussion. Speakers: • Leeona Galligan • All Panelists |
| 12.00pm | Wrap Up and Close Almac Speaker: • Michael Sloan |
| 12.00 – 13.00pm | Lunch Networking Lunch |
| Finish |
